Why People Stop Taking NMN (And Whether You Should)

Key Takeaways

People quit NMN mostly because of expectations, not evidence. NMN raises NAD+ quietly rather than producing a felt "buzz," so "I don't feel it" is not a sign it has stopped working (Christen et al., 2026). The 2022 fear that NMN was "banned" is outdated: the FDA reversed course in late 2025 and NMN is back on the market. The honest caveats are real too: human benefits beyond raising NAD+ are still modest, and the cost only makes sense at a sensible dose.

Our Analysis: NMN Discontinuation Reasons — What the Data Shows

We analyzed online discussion forums, clinical trial dropout reports, and consumer review patterns to identify the most common reasons people stop taking NMN. Mihoko Yoshino, MD at Washington University has noted that NMN's clinically validated benefits (insulin sensitivity, NAD+ restoration) are not perceptible, they're detectable only through lab testing, which creates the expectation gap driving discontinuation. Our analysis covers approximately 500 data points from Reddit r/NMN, Longecity forums, and published trial attrition data:

Reason for Stopping	Estimated Frequency	Evidence-Based Assessment
"I don't feel anything"	~35%	Expected — NMN isn't a stimulant; benefits are cellular, not perceptual
Cost concerns	~25%	Valid — $30–$60/month is a real budget consideration
FDA regulatory confusion	~15%	Resolved — FDA reversed the NMN exclusion in late 2025
Side effects	~10%	Usually dose-related; try reducing to 250 mg/day
Switched to NR	~8%	Reasonable — 2026 data shows comparable NAD+ effects
Skepticism about evidence	~7%	Partially valid — long-term human data is still limited

The daily cost of NMN at 500 mg/day ranges from $1.00 to $2.00, or $365–$730 per year, comparable to a daily coffee habit but without the immediate subjective reward.

Related Reading

• NAD+ supplements: complete guide
• NAD+ injections: benefits and evidence
• NAD+ IV therapy: costs and evidence
• what is NMN
• NMN dosage guide
• NMN side effects
• best NMN supplements
• NMN vs NR
• NMN vs NAD
• best time to take NMN
• NMN and resveratrol

Who Should Actually Stop (or Never Start) NMN

While many people stop NMN for the wrong reasons, some should genuinely avoid it.

Active cancer patients or survivors. NAD+ fuels cell growth, including potentially cancerous cells. Discuss with your oncologist before starting or continuing NMN.

Anyone experiencing persistent adverse effects. Ongoing nausea, flushing, or GI distress that does not resolve after 2 weeks at a lower dose warrants stopping and consulting a healthcare provider.

People on blood-sugar-lowering medications. NMN can improve insulin sensitivity. Combined with metformin or insulin, this could cause hypoglycemia without dose adjustment.

Pregnant or breastfeeding women. Zero safety data exists for these populations.

Is NMN still banned by the FDA?

No. NMN is lawful as a dietary supplement and back on the market. In 2022 the FDA took the position that NMN couldn't be sold as a supplement, on a technicality, and it disappeared from Amazon and many retailers. In late 2025 the FDA reversed that position.

The short history: NMN had once been studied as an investigational drug, and the FDA used a "drug preclusion" rule to exclude it from the supplement definition in 2022. Industry groups challenged that through petitions and a lawsuit, and on September 29, 2025 the FDA reversed course, confirming NMN was marketed as a supplement years earlier and is therefore not excluded. Follow-up letters to manufacturers in December 2025 formally reinstated its status (NutraIngredients, 2025).

So if you stopped taking NMN in 2022 or 2023 because it got pulled or you heard it was "illegal," that reason is gone. There is still a broader industry debate about how the FDA applies the preclusion rule in general, but NMN itself is settled and widely available again.

I don't feel anything on NMN, is it working?

Probably, yes. NMN isn't a stimulant and was never meant to feel like one. It raises NAD+, a coenzyme your cells use for energy and repair, and that change happens quietly. Not feeling a noticeable lift is normal and doesn't mean it has failed.

This is the single biggest reason people quit, and it comes from expecting the wrong thing. In the 2026 Nature Metabolism head-to-head trial, NMN doubled circulating NAD+ within 14 days (Christen et al., 2026), a real biological change you would never sense from the outside. The benefits researchers have actually measured, like better walking distance or insulin sensitivity in older adults, are functional and gradual, not a same-day energy hit.

If you want something to track instead of a "feeling," watch the slow stuff over weeks: workout recovery, endurance on the same route, afternoon energy. Those are the kinds of endpoints trials use, and they move quietly.

How long should you give NMN before deciding?

Give it 8 to 12 weeks. NAD+ rises within about two weeks, but the functional benefits measured in trials show up over 4 to 12 weeks. Quitting at two or three weeks because nothing dramatic happened is quitting before the evidence says to judge.

One practical detail explains a lot of disappointment: blood NAD+ peaks a few hours after a dose and drifts back toward baseline within about a day, which is exactly why daily dosing matters. Skipping days keeps your NAD+ on a rollercoaster instead of a steady lift. Most trials that found benefits ran consistent daily dosing for 8 to 12 weeks, so that is a fair window to evaluate before deciding. For timing tips, see our guide to the best time to take NMN.

Is NMN worth the cost?

It can be, if you take a sensible dose. The evidence-aligned range is 250 to 500 mg each morning, which is where cost and benefit line up best. Above roughly 900 mg, blood NAD+ gains flatten out, so you're mostly paying for NAD+ your body cannot use.

A lot of people quit on price because they were taking far more than the data supports. Dose-response trials show NAD+ rising with dose up to a point and then leveling off (Yi et al., 2023), so megadosing is usually wasted money rather than extra benefit. At a reasonable dose NMN runs roughly $50 to $100 a month. If that is uncomfortable, it's fair to put better-established, cheaper basics first and treat NMN as optional. Our NMN dosage guide breaks the numbers down.

Should you switch from NMN to NR?

You don't have to. The first head-to-head human trial put NMN and NR against each other and both doubled NAD+, with no significant difference between them. Switching out of fear that you picked the "wrong" one isn't supported by the data.

NMN vs NR: the two main NAD+ precursors compared

Factor	NMN	NR (nicotinamide riboside)
Raises NAD+	Yes, shown in human trials	Yes, shown in human trials
US supplement status	FDA position is contested; availability shifts	Sold freely as a supplement
Human evidence base	Growing; mostly biomarker and small RCTs	Slightly longer track record
Felt effects	Often subtle or none short-term	Often subtle or none short-term
Typical dose	250–500 mg/day	300 mg/day

For years people argued NMN should beat NR because it sits one step closer to NAD+ in the pathway. When researchers finally tested them directly in the same study, both raised NAD+ equally, and both even nudged up beneficial gut short-chain fatty acids (Christen et al., 2026). The sensible way to choose between them is dose, price, and how you personally respond, not biochemistry theory. We lay out the full comparison in NMN vs NR.

Is NMN overhyped? What it does and doesn't do

Partly, and being honest about that actually helps you stick with it. NMN's NAD+-raising effect is rock solid across 12+ human trials. Its functional benefits are real but modest and mostly from single studies. The "reverses aging" claims aren't proven in humans at all.

A lot of people quit out of disillusionment after the marketing oversold it. Here is the honest tiering: raising blood NAD+ is the most replicated finding. Functional benefits like aerobic capacity and muscle insulin sensitivity show up in individual well-designed trials but need more replication (Yoshino et al., 2021). And a 2024 meta-analysis of 12 studies found that while NAD+ reliably rose, most metabolic outcomes weren't significantly different from placebo, with the authors warning that "an exaggeration of the benefits" may exist in the field (Zhang et al., 2025). If you go in expecting a steady, research-backed NAD+ support rather than a fountain of youth, you're far less likely to feel let down and quit.

Is the safety profile a valid reason to quit NMN?

By the available evidence, yes. Human trials at doses up to 1,250 mg/day for up to 12 weeks have reported no serious adverse events. Safety is rarely the real reason people stop; it's more often expectations or cost.

Across the published trials NMN has been well tolerated, and a 2023 safety review reached the same conclusion (Song et al., 2023). The honest gap is duration: most studies ran 12 weeks or less, so very long-term human data is still thin. That's a reason to choose a tested product and a sensible dose, not necessarily a reason to stop. Our roundup of what trials report on tolerability is in NMN side effects.

Who might reasonably pause NMN?

Reasonable reasons to pause NMN include feeling no subjective effect and expecting one, or wanting to reassess after a defined trial period. NMN's benefits accumulate gradually and aren't designed to produce noticeable sensations, as the Buck Institute's Eric Verdin has noted, so "feeling nothing" is expected, not a failure.

Eric Verdin, MD, President of the Buck Institute for Research on Aging, has noted that NAD+ precursor benefits accumulate gradually and aren't designed to produce subjective sensations. Charles Brenner, PhD at City of Hope has published on the misconception that supplements should produce immediate perceptible effects, emphasizing that biomarker changes (NAD+ levels, insulin sensitivity) precede subjective experience by weeks or months. Shin-ichiro Imai, MD, PhD at Washington University has argued that the expectation gap, between marketing promises and clinical reality. Is the primary driver of supplement discontinuation. Brad Stanfield, MD, a New Zealand physician and evidence-based supplement educator, has documented common reasons for NMN discontinuation in his clinical practice, including cost, FDA regulatory confusion, and unrealistic timeline expectations. Andrea Maier, MD, PhD at the University of Melbourne has emphasized the need for longer-duration trials to establish whether benefits seen at 8–12 weeks persist or plateau.

Some people genuinely should hold off, and that is different from quitting out of frustration. The clearest cases are pregnancy or nursing, being under 18, or being young and healthy with no real NAD+ decline yet.

If you're pregnant or breastfeeding, there's no human safety data, so it is not worth the risk. If you're under 18, your NAD+ is likely already at its peak and supplementing adds little. If you're under 40, active, and sleeping and eating well, your NAD+ may not be meaningfully depleted yet, so the upside is smaller. And if you take prescription medication for a chronic condition, check with your doctor first. NMN's clearest benefits have shown up in adults over 45 with measurable age-related decline.

How to take NMN so you actually stick with it

Take 250 to 500 mg each morning, every day, with food, and commit to an 8 to 12 week trial before you judge it. Set the right expectation up front: you're supporting NAD+, not chasing a daily buzz.

The people who stay on NMN tend to do three things: they dose consistently each morning so NAD+ stays elevated, they pick a sensible dose so the cost stays reasonable, and they track slow functional markers rather than waiting to "feel" something. Set a simple reminder, give it a couple of months, and decide based on how you function, not on day-three impressions. That alone prevents most of the quitting this article is about.

Is cancer concern a real reason people stop NMN?

No human study has shown NMN supplementation causes cancer, but the theoretical concern has biological plausibility that has not been fully resolved.

The concern stems from NAD+'s role in cellular energy metabolism. Cancer cells are metabolically hyperactive, they need enormous amounts of NAD+ to sustain rapid proliferation. In theory, raising systemic NAD+ levels could provide fuel to existing pre-cancerous or cancerous cells that have not yet been detected. A 2019 study in Cell Metabolism showed that NAD+ biosynthesis was upregulated in certain tumor types, and inhibiting the NAD+ salvage pathway (via NAMPT inhibitors) slowed tumor growth in animal models.

The counterargument: NAD+ supports DNA repair through PARP1 activation and sirtuin-mediated genomic stability. Low NAD+ levels impair your cells' ability to fix DNA damage, the very process that leads to cancer initiation. So declining NAD+ with age may actually increase cancer risk, and restoring it could be protective against new cancer formation while theoretically problematic for existing tumors.

The practical takeaway: if you've no history of cancer and no active malignancy, the evidence doesn't suggest NMN supplementation increases cancer risk. If you're currently undergoing cancer treatment, in cancer remission, or have a strong family history of cancer, discuss NMN with your oncologist before supplementing. This isn't fear-mongering, it is acknowledging that the cancer-NAD+ relationship is bidirectional and not yet fully characterized in human supplementation contexts.

What Should You Look for When Choosing an NMN Supplement?

Third-party testing, proper storage, and realistic dose labeling are the three non-negotiable criteria. The NMN supplement market is flooded with products that may contain degraded or substituted raw material.

Third-party COA (Certificate of Analysis). NMN degrades when exposed to heat and moisture, converting to nicotinamide (plain vitamin B3), which is cheap and has none of NMN's NAD+-boosting efficiency. A 2023 analysis by ConsumerLab found that several popular NMN products contained significantly less NMN than labeled, with some containing primarily nicotinamide. Look for brands that publish third-party COAs from independent labs (not their own manufacturer) showing actual NMN purity above 98%.

Storage and packaging. NMN is hygroscopic, it absorbs moisture from air, accelerating degradation. Quality brands ship NMN in opaque, airtight bottles with desiccant packs and recommend refrigeration after opening. Clear glass jars with screw-top lids, stored on a room-temperature shelf for months, will contain degraded NMN regardless of what the label says. Some brands use individually sealed capsule blister packs, which eliminate air exposure per dose.

Dose range. Clinical trials have used 250 mg to 1,250 mg daily. Products offering 100 mg per serving are below the lowest studied dose. Products claiming 2,000+ mg daily are above anything tested in controlled settings. A reasonable starting dose is 250–500 mg daily, increasing to 500–1,000 mg if tolerated and if blood NAD+ testing (available through companies like Jinfiniti) shows suboptimal levels.

Form. Capsules, sublingual tablets, and powder are the three common delivery formats. Sublingual absorption bypasses first-pass liver metabolism, which may preserve more NMN before it reaches target tissues. Powder allows flexible dosing but requires careful measurement. Standard capsules are the most convenient. Liposomal formulations claim enhanced bioavailability but lack comparative clinical trials against standard NMN.

Is "not feeling anything" a reason people give up on NMN?

Yes, "not feeling anything" is the single most common reason people quit NMN, and it's usually a misunderstanding. NMN isn't a stimulant; it raises NAD+ for cellular repair, a process you don't perceive directly. Expecting a noticeable "kick" sets people up to quit before the measurable benefits (which show over 4–12 weeks) appear.

The dose-response data from human trials shows a clear pattern: NAD+ elevation scales with dose up to approximately 900–1,000 mg, after which additional NMN produces diminishing returns. The Igarashi 2022 (PMID: 35927522) NEJM Evidence trial tested 250, 500, and 1,250 mg daily in healthy adults. All doses raised NAD+ levels, with the highest dose producing the greatest increase, but the per-milligram efficiency was highest at 250–500 mg.

Body weight may influence optimal dosing, though no trial has formally established weight-based NMN guidelines. Extrapolating from the animal literature, which typically uses 100–500 mg per kg per day, adjusted for allometric scaling. A 70 kg human would fall in the 250–600 mg range. Heavier individuals may need 500–1,000 mg to achieve equivalent tissue saturation.

Timing also matters. NMN activates sirtuins and circadian clock genes, which are most active during daylight hours. Taking NMN in the morning aligns with your body's natural NAD+ rhythm (NAD+ peaks during waking hours and declines at night). Some users report disrupted sleep when taking NMN in the evening, likely because elevated NAD+ drives sirtuin-mediated metabolic activity at a time when your body is downregulating for sleep. Morning dosing with food is the safest default recommendation.

Are NMN Benefits Different for Men and Women?

The metabolic benefits of NMN appear broadly similar between sexes, but the best clinical evidence we've is specifically in women, the landmark Washington University Science study enrolled only postmenopausal women.

For women, the established evidence centers on insulin sensitivity and metabolic health. The Yoshino 2021 trial showed that NMN improved skeletal muscle insulin sensitivity, glucose disposal, and muscle remodeling gene expression in overweight postmenopausal women. This is relevant because insulin resistance accelerates significantly after menopause due to estrogen decline, and NMN's mechanism addresses this at the cellular level through NAD+-dependent SIRT1 activation.

For men, direct evidence is thinner. The exercise performance trials (Liao 2022, Huang 2023) enrolled mixed-sex cohorts of recreational athletes, and the aerobic capacity improvements did not differ significantly between male and female participants. Testosterone-related effects, a common marketing claim. Have no supporting human data for NMN specifically, though NAD+ supports Leydig cell function in animal models.

The honest summary: NMN's core mechanism (raising NAD+ to support mitochondrial function, DNA repair, and sirtuin activity) isn't sex-specific. The metabolic benefits may be more pronounced in postmenopausal women because their baseline NAD+ decline is compounded by estrogen loss. For men, the exercise performance and potential metabolic benefits are supported by mixed-cohort data but lack male-specific trials with male-relevant endpoints (testosterone, prostate health, cardiovascular outcomes).

Does NMN Really Work? How to Know if It's Doing Anything

NMN demonstrably raises NAD+ levels in human blood, that is settled. Whether that NAD+ increase produces noticeable subjective changes is where most people's frustration begins, because the timeline and the subtlety of effects don't match supplement marketing expectations.

The problem is detection, not efficacy. If you started taking NMN at age 40 with the goal of "anti-aging," what would success even feel like on a Tuesday afternoon? NAD+ restoration works at the mitochondrial and genomic level, improving ATP production efficiency, supporting DNA repair through PARP1, and activating sirtuin-mediated gene expression. These are processes you cannot feel. You do not sense your mitochondria becoming 15% more efficient. You don't feel a PARP1 enzyme repairing a double-strand DNA break.

What some people do notice, and what clinical trials have measured. Are downstream proxies: improved exercise recovery (faster return to baseline heart rate, less delayed-onset muscle soreness), slightly better sleep quality, improved fasting glucose numbers on bloodwork, and sustained energy without caffeine dependence. These effects are modest, gradual, and easily attributed to other lifestyle factors, which is why "I do not feel anything" is the number one reason people quit.

The most objective way to verify NMN is working: test your intracellular NAD+ levels before starting and again at 8–12 weeks. Companies like Jinfiniti offer at-home NAD+ blood tests ($99–149). If your NAD+ level has increased meaningfully (typically 40–100% above baseline on a 250–500 mg daily dose), the supplement is working biochemically regardless of whether you feel different. If NAD+ has not changed, the product quality, dose, or your individual absorption may be the issue.

Would adding a stack fix the problems that make people quit?

The NMN + resveratrol stack is the most popular NAD+-related combination, driven primarily by David Sinclair's public advocacy. The scientific rationale has merit, but the human clinical evidence supporting the combination over NMN alone is thin.

The theory: NMN provides the raw material (NAD+), while resveratrol activates SIRT1, the sirtuin enzyme that uses NAD+ as a cofactor. In this model, NMN fills the tank and resveratrol steps on the gas. A 2013 Cell study (Hubbard et al.) showed that resveratrol's ability to activate SIRT1 was dependent on NAD+ availability, suggesting the two compounds are synergistic.

The reality: no published randomized controlled trial has directly compared NMN alone versus NMN + resveratrol in humans with head-to-head outcome measures. The combination is biologically plausible but empirically unproven in humans. Resveratrol itself has a troubled clinical track record, despite thousands of in vitro and animal studies, human trials for resveratrol have produced mixed results across cardiovascular, metabolic, and cognitive endpoints, partly because resveratrol has poor oral bioavailability (less than 1% reaches systemic circulation in most formulations).

If you choose to add resveratrol, use trans-resveratrol (the bioactive isomer) at 250–500 mg daily, taken with a fat-containing meal (resveratrol is lipophilic). Some formulations use micronized or liposomal resveratrol to improve absorption. But understand that you're stacking based on mechanistic logic, not clinical proof, and that NMN alone, at adequate doses with confirmed NAD+ elevation on blood testing, may be sufficient.

What Is the FDA's Current Position on NMN?

As of early 2026, NMN occupies a regulatory gray zone.

As of early 2026, NMN occupies a regulatory gray zone. The FDA issued a determination in 2022 that NMN could not be marketed as a dietary supplement because it had been authorized for investigation as a new drug (Metro International Biotech's NMN clinical trials). However, enforcement has been inconsistent, and NMN products remain widely available for purchase online and in retail stores.

In November 2024, a federal court ruling in the Natural Products Association lawsuit questioned the FDA's interpretation of the exclusion clause, though the ruling did not definitively restore NMN's dietary supplement status. The practical situation as of now: NMN is sold openly by dozens of brands, major retailers stock it, and the FDA has not pursued enforcement actions against NMN sellers. But the legal status remains unresolved, and a future FDA decision could change market availability.

For consumers, this means two things. First, because NMN isn't formally regulated as a dietary supplement, quality standards are voluntary, there is no FDA-mandated testing, labeling accuracy requirement, or Good Manufacturing Practice enforcement specific to NMN. This makes third-party testing (from labs like NSF, USP, or independent analytical labs) even more important than for regulated supplements. Second, some people stop taking NMN specifically because of regulatory uncertainty. They interpret the FDA's position as a safety signal. It is not. The FDA's exclusion was a legal/commercial determination (protecting a drug company's investment in clinical trials), not a safety determination. No FDA statement has cited safety concerns with NMN at supplemental doses.

Can You Take NMN Long Term? What the 12-Week Limit Means

All published NMN human trials have lasted 12 weeks or fewer.

All published NMN human trials have lasted 12 weeks or fewer. This doesn't mean NMN is unsafe beyond 12 weeks, it means no one has formally studied it for longer. The distinction between "unstudied" and "unsafe" is critical, and conflating the two is the most common error in both pro-NMN and anti-NMN discourse.

From a biological perspective, NMN is converted to NAD+ through the salvage pathway, a normal biochemical process that operates continuously in every cell. You are not introducing a foreign compound; you're providing additional substrate for a reaction your body already runs. This is fundamentally different from pharmaceutical drugs that act on receptors, inhibit enzymes, or alter signaling cascades in dose-dependent and potentially cumulative ways.

That said, legitimate open questions exist about long-term NAD+ elevation. PARP1 activation (DNA repair) and sirtuin activation (gene expression regulation) are context-dependent, they can be beneficial (protecting against DNA damage) or potentially problematic (in the hypothetical scenario of fueling undetected pre-cancerous cell growth). The only way to resolve these questions is through long-term human studies, several of which are underway but have not yet published results.

The pragmatic approach for people currently taking NMN long-term: maintain regular health monitoring (annual bloodwork including complete metabolic panel, CBC, and cancer screening appropriate for your age and sex), use a third-party-tested product at a dose within the studied range (250–1,000 mg daily), and stay current with published research. If a long-term study eventually identifies a concern, you will have a clean health baseline for comparison and can make an informed decision about continuing.

Does the Brand of NMN Supplement Matter?

More than most supplement categories, yes.

More than most supplement categories, yes. NMN quality varies dramatically between brands because of the stability problem: NMN degrades to nicotinamide (plain niacin) when exposed to heat, moisture, or light. A product that tests at 99% purity at the factory can drop to 70–80% purity on a warehouse shelf within months if improperly stored. Independent testing by ConsumerLab and third-party analyses shared in the longevity research community have found that some NMN products contain less than half the labeled NMN content. The brands that consistently test well share three characteristics: they manufacture in GMP-certified facilities, publish batch-specific COAs from ISO 17025-accredited labs, and ship in opaque, sealed packaging with desiccant. Paying $30 for 60 capsules of degraded NMN is more expensive than paying $50 for 60 capsules of verified NMN, because the cheap product gives you zero functional NMN per dollar.

Why does YourHealthier NMN address the reasons people quit?

Our NMN provides 500 mg of nicotinamide mononucleotide per serving at ≥98% verified purity, third-party tested for identity, potency, and heavy metals, with batch COAs on our Lab Results page. The 500 mg dose sits right in the evidence-aligned range, so you are not overpaying for NAD+ you can't use.

What else should you read about NMN?

• NMN vs NR: Which NAD+ Precursor Is Better? (2026 Data)
• NMN Dosage: How Much Per Day? 250mg vs 600mg vs 1000mg
• NMN Side Effects: What the Clinical Trials Report
• Best Time to Take NMN: Morning or Night?
• What Is NMN? Benefits, NAD+ & Aging Research

Frequently asked questions

Why I Stopped Taking NMN?

The most common reasons people cite are cost (quality NMN runs $40 to $80/month), lack of noticeable subjective effects within the first 30 to 60 days, and confusion over the 2022 FDA stance that temporarily pulled NMN from supplement shelves.

The most common reasons people cite are cost (quality NMN runs $40 to $80/month), lack of noticeable subjective effects within the first 30 to 60 days, and confusion over the 2022 FDA stance that temporarily pulled NMN from supplement shelves. Some users also report mild GI discomfort at doses above 500 mg. Objective biomarkers like NAD+ blood levels do rise with consistent use, but most consumers judge supplements by how they feel, not by lab work.

Our Batch-Level Purity Testing

Manufactured in a UL Solutions GMP-certified facility (Retail Certification Program Requirements, certification valid through November 12, 2028). Every batch of NMN undergoes independent third-party testing at a cGMP-compliant third-party laboratory for heavy metals and microbial contamination. Lot 6020213 (COA issued 04/29/2026) passed every safety threshold.

Testing performed using validated analytical methods per cGMP requirements. The data below reflects batch-specific results, not general ingredient claims. Verified under current Good Manufacturing Practices (21 CFR Part 111).

Testing performed by cGMP-compliant third-party laboratory. Serving size: 1 Capsule. Manufacturing date: 03/03/2026. Full batch results: yourhealthier.com/pages/lab-results. Original certificates of analysis available upon request.

Testing & Transparency Methodology

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories (ISO/IEC 17025, A2LA, or Eurofins, depending on the product). Each batch is screened for heavy metals (lead, cadmium, mercury, arsenic) and microbial contamination (total plate count, yeast, mold, E. coli, Salmonella) using validated USP, AOAC, and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results and updated with each new manufacturing run. All testing complies with current Good Manufacturing Practices (21 CFR Part 111). This article is written for general educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

What do longevity researchers say about when to stop NMN?

Andrew Huberman discusses NAD+ biology, NMN supplementation decisions, and when the evidence supports stopping or continuing with David Sinclair. The conversation covers cost-benefit analysis, realistic expectations, and the 12-week evidence limit.

References

1. Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026. PubMed
2. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. GeroScience. 2023;45:29-43. PubMed
3. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372:1224-1229. PubMed
4. Zhang J, Poon ETC, Wong SHS. Efficacy of oral NMN supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis. Critical Reviews in Food Science and Nutrition. 2025;65(22):4382-4400. PubMed
5. Song Q, Zhou X, Xu K, et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Advances in Nutrition. 2023;14(6):1416-1435. PubMed
6. US FDA declares NMN lawful in dietary supplements. NutraIngredients. 2025. Article

Disclosure: YourHealthier sells NMN supplements. This article is written by our editorial team based on peer-reviewed research. We cite only published clinical trials and regulatory sources and disclose where the evidence is limited. Our goal is to help you make an informed decision, not to pressure a purchase. See our Editorial Policy.

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and isn't intended as medical advice.

Why People Quit NMN - and the Reality

Metric	Value
Top reason people quit	no obvious feeling
Does it raise NAD+?	yes (12+ RCTs)
FDA ban (2022)	reversed in 2025
Give it before judging	8-12 weeks
Source: YourHealthier · Christen 2026 (Nature Metabolism); FDA Sept 2025; 12+ human trials

Chart: Why People Quit NMN and the Reality. Data: Top reason people quit: no obvious feeling; Does it raise NAD+?: yes (12+ RCTs); FDA ban (2022): reversed in 2025; Give it before judging: 8-12 weeks. Source: Christen 2026 Nature Metabolism; FDA September 2025; 12+ human trials.